- Benzimidazole or azabenzimidazole -6 - carboxylic acid compound and application thereof
-
The invention discloses benzimidazole or azabenzimidazole -6 - carboxylic acid compound and application thereof, wherein the benzimidazole or azabenzimidazole -6 - carboxylic acid compound has the structure shown in the formula (I). The benzimidazole or a
- -
-
Paragraph 0094; 0119-0120
(2021/10/11)
-
- GLP-1R AGONISTS AND USES THEREOF
-
Provided herein are compounds of Formula (I) and pharmaceutical compositions thereof, for use in, e.g. treating type 2 diabetes mellitus, pre-diabetes, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and cardiovascular disease.
- -
-
Page/Page column 59; 70; 71
(2020/10/21)
-
- GLP-1 Agonists and Uses Thereof
-
Provided herein are 6-carboxylic acids of benzimidazoles and 4-aza-, 5-aza-, 7-aza- and 4,7-diaza-benzimidazoles as GLP-1R agonists, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.
- -
-
Paragraph 0429
(2018/07/05)
-
- AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS
-
Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, N-oxides, or solvates thereof, [formula (I) should be inserted here]. Also provided herein are pharmaceutical compositions comprising compounds of Formula (I) and methods
- -
-
Page/Page column 114; 158
(2016/11/17)
-
- THE NITROPYRIDINYL ETHYLENEIMINE COMPOUND, THE PHARMACEUTICAL COMPOSITION CONTAINING IT, THE PREPARATION METHOD AND USE THEREOF
-
The present invention discloses a nitropyridinyl ethyleneimine compound as shown in the formula I and a preparation method of the same, as well as use of the compound in manufacture of a prodrug and in manufacture of a drug for treating a tumor.
- -
-
Page/Page column 12
(2011/10/10)
-